Trump built a tariff wall, Indian pharma found a European gate

Large Indian generic exporters are expanding their presence in European markets via a spate of acquisitions in that region, at a time when the Trump administration is turning increasingly protectionist. However, the global pharma market faces considerable uncertainties and investors can adopt a wait-and-watch attitude before making any investments in this sector.